483
Senores PharmaceuticalsSenores Pharmaceuticals – FDA 483, Mar 28, 2025
Record Details
Senores Pharmaceuticals in Hoschton, GA, was cited for significant delays in submitting both quarterly and annual periodic adverse drug experience reports (PADERs) for multiple approved drugs. The inspection, conducted from March 25-28, 2025, revealed numerous instances where these critical safety reports were submitted well past their regulatory deadlines, indicating a systemic issue with postmarketing surveillance compliance.
View Company Profile
ID · 434177cd-583d-48a7-b9aa-4515358d8665
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.